The follow-up examination on November 9, 2020 showed a mass-like consolidation shadow with a strip in the left lower lung (4.6x3.8cm);

     

From March 16, 2022, to March 8, 2024, follow-up examinations revealed changes consistent with left lower lung lobectomy, with no signs of metastasis in the chest.      

04            

             

       

Conclusion and Review< H83>

Conclusion and Commentary            

What else can we do after the surgery?

After experiencing recurrence and metastasis, Ms. Wang and her family discovered that her treatment could have avoided many detours.

       

Fighting cancer is not about passively receiving treatment, but actively managing risks. Instead of waiting for recurrence in worry and fear, it's better to hold the decision-making power of your life in your own hands.        

    

Don't let the illusion of healing become a breeding ground for recurrence!

Professor Zhang Minghui pointed out that the best time for Ms. Wang to receive vNKT treatment is after her first surgery. At this time, the tumor burden is at its lowest, but the lymphocytes (such as vNKT and CD8+ T cells) in the blood are significantly reduced due to surgery and chemotherapy, causing the immune system to be in a "paralyzed" state. Cancer cells that have broken through into the blood and lymphatic systems take the opportunity to metastasize. If Ms. Wang receives timely treatment after her first surgery, she can reduce the risk of recurrence and avoid a second surgery.

    

Under traditional treatment, the 5-year survival rate for lung adenocarcinoma with lymph node metastasis is approximately 50%. Ms. Wang has been recurrence-free for 4 years post-surgery, and her physical strength, infection frequency, and other indicators have improved, confirming the long-term benefits of immunotherapy.

       

She spent 4 years verifying a truth: Cancer treatment is never just about removing the tumor. Surgery is the starting point, but immune reconstruction is the end goal.

On the road to fighting cancer, you are not alone

         

Lehehuanyou Group: This is a dedicated communication and interaction platform for patients, where everyone shares treatment experiences, disease knowledge, exchanges ideas, helps each other, and works together to overcome illness.        

       

This is not only a community full of positive energy, where members support each other and inspire each other, but also a warm harbor. The topics that patients exchange here are not only about diseases, but also about blessings, greetings, joyful news shared, and even some interesting stories, encouragement, and comfort in life.        

       

Join the Lehehuanyou group and embark on a journey of warmth!

       

         

Lian

is a

I

       

Add Lehe and Little Assistant, join the Lehe Patient and Friend Group

     

         

         

Zhang Minghui

Founder of Lehe New Medicine

         

Professor Zhang Minghui, who holds a PhD in Immunology from Tsinghua University School of Medicine, has led a research team for over 20 years since the discovery of vNKT cells in 2002. They have accumulated treatment experience in over 700 cases of solid tumors, covering almost all common solid tumors. The research results fully demonstrate the great value of vNKT cells in the treatment of solid tumors.

It is suitable for post-operative patients with high pathological malignancy or a risk of recurrence; patients whose tumors have been basically controlled but not cured through conventional treatments such as chemotherapy, radiotherapy, and targeted therapy; patients with persistent high carcinogenic factors; and patients intolerant to radiotherapy and chemotherapy. If these patients do not receive effective follow-up treatment after traditional anti-tumor therapy, recurrence, metastasis, or reoccurrence of tumors will be highly probable. In this case, vNKT cell therapy is an ideal follow-up treatment method that can significantly improve patient prognosis.

Written by: Yizhituan      

Reviewed by: Qiao Jiacheng, Wang Ying, Gao Chen

Edited/typeset by Zhang Jiao      

   

Click on the image to view past exciting content

         

         

         

             

The fairies are all watching              

Click on the upper right corner of the homepage to set as star !